UBS Group AG - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$4,020,211
-34.3%
80,052
-17.3%
0.00%
-50.0%
Q2 2023$6,115,612
+36.4%
96,766
-2.9%
0.00%
+100.0%
Q1 2023$4,484,289
-24.1%
99,673
-26.1%
0.00%
-50.0%
Q4 2022$5,908,130
+854.5%
134,858
+1334.7%
0.00%
Q3 2022$619,000
-63.2%
9,400
-71.7%
0.00%
-100.0%
Q2 2022$1,680,000
-45.6%
33,248
-31.2%
0.00%0.0%
Q1 2022$3,086,000
-55.2%
48,303
-24.9%
0.00%
-50.0%
Q4 2021$6,889,000
+27.2%
64,321
+22.0%
0.00%0.0%
Q3 2021$5,418,000
+199.0%
52,704
+155.8%
0.00%
+100.0%
Q2 2021$1,812,000
-71.4%
20,603
-68.4%
0.00%
-50.0%
Q1 2021$6,331,000
+219.3%
65,113
+268.3%
0.00%
+100.0%
Q4 2020$1,983,000
+288.8%
17,677
+221.5%
0.00%
Q3 2020$510,000
-25.3%
5,499
-37.2%
0.00%
Q2 2020$683,000
+187.0%
8,753
+115.3%
0.00%
Q1 2020$238,000
-87.8%
4,066
-83.3%
0.00%
-100.0%
Q4 2019$1,952,000
-55.7%
24,366
-59.3%
0.00%
-50.0%
Q3 2019$4,403,000
+8207.5%
59,930
+10601.8%
0.00%
Q2 2019$53,000
+96.3%
560
+67.2%
0.00%
Q1 2019$27,000
-98.5%
335
-99.0%
0.00%
-100.0%
Q4 2018$1,841,000
+3.3%
34,134
+49.4%
0.00%0.0%
Q3 2018$1,783,000
-75.0%
22,846
-79.7%
0.00%
-66.7%
Q2 2018$7,135,000
+36.9%
112,390
+97.8%
0.00%
+50.0%
Q1 2018$5,210,000
+305.4%
56,818
+233.4%
0.00%
+100.0%
Q4 2017$1,285,000
-44.8%
17,044
-49.0%
0.00%0.0%
Q3 2017$2,330,000
+101.2%
33,435
+46.4%
0.00%0.0%
Q2 2017$1,158,000
+295.2%
22,841
+211.7%
0.00%
Q1 2017$293,000
-18.6%
7,328
-42.9%
0.00%
Q4 2016$360,000
+267.3%
12,829
+287.0%
0.00%
Q3 2016$98,000
+69.0%
3,315
+14.3%
0.00%
Q2 2016$58,000
-63.3%
2,900
-67.0%
0.00%
Q1 2016$158,000
-29.1%
8,801
+3.9%
0.00%
Q4 2015$223,000
+25.3%
8,472
+1.4%
0.00%
Q3 2015$178,000
-14.0%
8,351
+6.7%
0.00%
Q2 2015$207,0007,8250.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders